tm
Seeing Is Believing
tm
Seeing Is Believing
TARS is currently covered by 6 analysts with an average price target of $105.68. This is a potential upside of $24.91 (30.84%) from yesterday's end of day stock price of $80.77.
Tarsus Pharmaceuticals 's activity chart (see below) currently has 56 price targets and 43 ratings on display. The stock rating distribution of TARS is 90% BUY and 10% HOLD.
Analysts average stock forecasts to be materialized ratio is 93.75% with an average time for these price targets to be met of 513 days.
Highest price target for TARS is $100, Lowest price target is $51, average price target is $73.33.
Most recent stock forecast was given by ANTHONY PETRONE from JEFFERIES on 20-Nov-2025. First documented stock forecast 10-Nov-2020.
Currently out of the existing stock ratings of TARS, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 22-Jun-2021
$100
$19.23 (23.81%)
$58
1 months 16 days ago
(20-Nov-2025)
3/4 (75%)
$22.89 (29.68%)
477
Hold
Since 20-Nov-2023
$51
$-29.77 (-36.86%)
$41
8 months ago
(05-May-2025)
4/4 (100%)
$3 (6.25%)
87
Buy
Since 16-Jun-2023
$84
$3.23 (4.00%)
8 months 3 days ago
(02-May-2025)
3/4 (75%)
$36.64 (77.36%)
457
Buy
Since 21-Dec-2021
$73
$-7.77 (-9.62%)
$61
10 months 10 days ago
(26-Feb-2025)
10/10 (100%)
$30.44 (71.52%)
564
Buy
Since 01-Aug-2022
$60
$-20.77 (-25.71%)
$62
10 months 10 days ago
(26-Feb-2025)
5/5 (100%)
$17.44 (40.98%)
415
What is TARS (Tarsus Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals )?
Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals )?
Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals )?
